12/07/2022
Effective November 15, 2022, prior authorization for Synagis is not required.
Banner – University Family Care/ACC is pausing prior authorization requirements this season for Synagis® (palivizumab). Effective November 15, 2022, prior authorization for Synagis is not required. This is effective for the remainder of the 2022-23 RSV season.